SCHEMBL17295278

SCHEMBL17295278

CCCCCCCCCCCCN1C(=O)C(=Cc2ccc3[nH]ccc3c2)SC1=Nc1ccc(C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 1/20 0.47
▸ S1PR3 Q99500 1/20 0.47
▸ FAAH O00519 2/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ CA9 Q16790 3/20 0.44
▸ ALDH1A1 P00352 6/20 0.43
▸ MAPT P10636 5/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29726551 1.00 S1PR1 (0.47) S1PR1S1PR3FAAHSMN1; SMN2LMNA
SCHEMBL17295277 1.00 S1PR1 (0.47) S1PR1S1PR3FAAHSMN1; SMN2LMNA
SCHEMBL17302191 0.88 FAAH (0.57) FAAHSMN1; SMN2LMNAHPGDCA9
SCHEMBL17295272 0.81 FAAH (0.61) S1PR1S1PR3FAAHSMN1; SMN2LMNA
SCHEMBL17295271 0.81 FAAH (0.61) S1PR1S1PR3FAAHSMN1; SMN2LMNA
SCHEMBL17295392 0.80 PTPN1 (0.51) S1PR1S1PR3FAAHSMN1; SMN2LMNA
SCHEMBL17295389 0.80 PTPN1 (0.51) S1PR1S1PR3FAAHSMN1; SMN2LMNA
SCHEMBL17295335 0.80 FAAH (0.52) S1PR1S1PR3FAAHSMN1; SMN2LMNA
SCHEMBL17295336 0.80 FAAH (0.52) S1PR1S1PR3FAAHSMN1; SMN2LMNA
SCHEMBL17302215 0.80 CFTR (0.51) S1PR1S1PR3FAAHSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback